Infection, Human Immunodeficiency Virus

14 competing products in clinical development for Infection, Human Immunodeficiency Virus.

Pipeline by Phase

Phase 18

Phase 23

Phase 33

All Products (14)

Product	Company	Stage	Status	Hype
Dolutegravir	Shionogi	Phase 3	Completed	40
dolutegravir	Shionogi	Phase 3	Completed	40
GSK1349572 + Raltegravir + GSK1349572 Placebo + Raltegravir Placebo	Shionogi	Phase 3	Completed	40
GSK1265744 30mg + Placebo + GSK1265744 5mg	Shionogi	Phase 2	Completed	35
GSK1349572 + efavirenz	Shionogi	Phase 2	Completed	35
GSK1349572 + Placebo	Shionogi	Phase 2	Completed	35
Dolutegravir 50 mg/abacavir 600 mg/lamivudine 300 mg + Dolutegravir 50 mg + abacavir 600 mg/lamivudine 300 mg	Shionogi	Phase 1	Completed	29
Ortho-Cyclen + Dolutegravir + Placebo	Shionogi	Phase 1	Completed	29
GSK1349572	Shionogi	Phase 1	Completed	29
GSK1349572 + Rifampin + Rifabutin	Shionogi	Phase 1	Completed	29
DTG + BCV + TVR	Shionogi	Phase 1	Completed	29
GSK1349572	Shionogi	Phase 1	Completed	29
Dolutegravir 50 mg	Shionogi	Phase 1	Completed	29
Dolutegravir + Prednisone	Shionogi	Phase 1	Completed	29